Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
0.9196
+0.0304 (3.42%)
At close: Sep 17, 2026, 4:00 PM EDT
0.9200
+0.0004 (0.04%)
After-hours: Sep 17, 2026, 4:41 PM EDT

Milestone Pharmaceuticals Revenue

Milestone Pharmaceuticals had revenue of $559.00K in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $2.34M. In the year 2025, Milestone Pharmaceuticals had annual revenue of $1.55M.

Revenue (ttm)
$2.34M
Revenue Growth
n/a
P/S Ratio
54.16
Revenue / Employee
$61,658
Employees
38
Market Cap
129.58M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.55M--
Dec 31, 2024---
Dec 31, 20231.00M-4.00M-80.00%
Dec 31, 20225.00M-10.00M-66.67%
Dec 31, 202115.00M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Cellectis63.82M
LENZ Therapeutics21.48M
Caribou Biosciences10.04M
Equillium4.39M
Inovio Pharmaceuticals65.34K
Revenue Rankings